Founded by two former pharmaceutical veterans, The Itero Group is a full-service pharmaceutical/biotech marketing and Healthcare communication & management consulting firm. Based on a traditional philosophy that a brands strategic advantage evolves through a clear understanding of its scientific platform, our leadership team blends 50 plus years of extensive client and healthcare agency side communications experience, providing a perfect prism to view your challenges and devise unique best-in- class deliverables that address client’s needs.
Our Mission is dedicating ourselves as an extension of your team to support you to effectively and efficiently communicate your brands strategic value and company’s vision.
Maureen Early formed The iTero Group early in 2017.
Prior to this she was the VP of Commercialization at Synthetic Biologics . In this newly created role, Ms. Early lead all commercial and marketing efforts for the Company’s current and future product portfolio.
She has over 25 years of global and domestic strategic marketing executive experience in the pharmaceutical industry working on products from pre-launch through post-launch, and during her career she has successfully launched several products, created effective anti-infective marketing programs and developed solutions to optimize brand lifecycles.More
Prior to joining Itero, John was recently US commercial Marketing lead for an investigational product in the Bayer Pharmaceuticals portfolio, laying the foundation for launch.
John has over 25 years global and domestic strategic marketing, sales and market research experience, including leadership positions on the healthcare agency & medical education side. That experience includes pre-launch strategy/positioning & execution through post launch, including life cycle strategies on highly successful blockbuster brands as well as orphan disease products.More